Global Pharmaceutical Markets

Publication Date	May 2008
Publisher	BCC Research
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	BCC00231

Price

£3,330.00
approximately: $4,851 | €3,843

PDF

Order above formats by FAX

Summary

Study Goals And Objectives

This Study Examines World Pharmaceutical Markets And Provides Pertinent Information About Sales And Production Of Pharmaceutical Products, As Well As Information About National Healthcare Systems And Drug Pricing Policies. The Report Covers 24 Countries In Detail And Provides Links To Relevant Information. There Are Also Profiles Of Larger Pharmaceutical And Biotechnology Companies, Complete With Revenue Histories.

Trends In Government Policies Concerning Drug Pricing And Reimbursement Are Examined. The Report Also Makes Predictions About Countries Whose Pharmaceutical Market Growth Is Likely To Grow Radically In The Next 5 Years.

Reasons For Doing The Study

Although The Pharmaceutical Industry Remains One Of The Most Profitable And Stable Industries In The World, Several Variables Are Forcing Fundamental Changes In Its Structure. They Are:

Increasing Government-Imposed Price Reductions In Prices
An Increasing Role Of Generic Substitutes (Especially In Europe)
The Emergence Of Bio-Pharmaceuticals And The Bio-Omics Revolution
Increasing Buyer Power Of Third-Party Payers, Government Buyers, And Health Maintenance Organizations
Increased Health Awareness Among Patients And Government Buyers
Changing Suppliers-enhanced Outsourcing, In-Licensing, Contract Research, And Manufacturing Activities.

Additionally, Changing World Demographics Are Influencing The Pharmaceutical Industry. They Include Population Aging, Declining Research And Development (R&D) Productivity, And The General Agreements On Tariffs And Trade (Gatt) And Trade Related Intellectual Property Rights (Trips).

Audience For The Report

This Report Is Directed At Decision-Makers In Each Industry Segment, As Well As At Individuals And Organizations Considering Investing In Drug Discovery Or Drug Discovery Technology. These People Include, But Are Not Limited To The Following:

Business Development Professionals
Venture Capitalists
Merger And Acquisition Executives
Market And Product Management Professionals
Chief Scientists And Technical Officers
Equipment Manufacturers
Reagent Suppliers

Scope And Format

The Scope Of This Study Encompasses The Major Sectors Of The World Pharmaceutical Industry And Major Geographical Markets. Bcc Research Has Analyzed The Forces Affecting The World Pharmaceutical Markets, Determined Their Impact On The Market Demand And Growth, And Also Presented The Growth Forecast Over The Next 5 Years. Key Forces Include The Increasing Role Of Substitutes (Generic Pharmaceuticals), Threat Of New Entrants (Biopharmaceuticals), Increasing Role Of Buyers (Governments, Insurance, Etc.), And Changing Suppliers.

Bcc Research Has Provided The Comprehensive Analyses Of The Industry On The Worldwide Basis And Also Provided The Detailed Profiles For 25 Leading Pharmaceutical Markets Across The Globe. For Each Of The Geographical Markets, We Have Presented The Sector Information, Pharmaceutical Distribution And Pricing, And Reimbursement And Regulations. In A Nutshell, The Report Provides The Reader With A One-Stop Analysis Of The Worldwide Pharmaceutical Industry.

Methodology And Information Sources

Market Data And Other Information Used In This Report Was Gathered From Interviews With Individuals In The Industry, As Well As A Thorough Review Of Technology And Markets Gathered From Secondary Sources. These Sources Include Company Annual, 10k And 10q Reports, Company Literature, Trade Literature, Trade Associations, And Online Sources. Note That The Author Of This Report Is Herself Involved In The Development Of A Compound For Amyotrophic Lateral Sclerosis.

Projections Were Based On Current And Historical Levels Of Funding And Revenues, Potential End Users, Likely Unit Prices And Rates Of Consumption. Final Projections Are Based On The Analysis Of Information From Primary And Secondary Sources. All Currency Conversions Were Made Based On The Average Value Of The Dollar During The Last Month Of The Year In Question. In Some Cases, Data Is Provided In The Original Currency For Readers Wishing To Make Their Own Comparisons. An Online Currency Converter Was Used For This Purpose.[1] All Forecasts Are Presented In Year 2008 Constant Dollars.

Content

Dawn Petersphm037b
Overall Global Pharmaceutical Markets L
Overview
Background On The Industry
Recent History
Benefits, Problems, And Regulation
Changes In The Industry
Healthcare Expenditures
Table Healthcare Expenditures, Countries In This Report, 2000 And 2005 (% Of Gdp)
The Pharmaceutical Industry
Table Worldwide Leading Ethical Pharmaceutical Companies: Sales And Market Share, 2006 And 2007 ($ Billions)
Research And Development Expenditures
Table Worldwide Leading Pharmaceutical Companies By R&D Spending, 2006 And 2007 ($ Billions)
Sector Performance
Branded Pharmaceuticals
Table Largest Pharmaceutical Markets (Overall), 2006 And 2007 ($ Billions, % Of Total)
Table Largest Pharmaceutical Markets (Branded), 2006 And 2007 ($ Billions, % Of Total)
Table Worldwide Leading Pharmaceutical Largest Pharmaceutical Markets (Generic), 2006 And 2007 ($ Billions, % Of Total)
Table Largest Pharmaceutical Markets (Otc), 2006 And 2007 ($ Billions, % Of Total)
United States
Introduction
Table Overall Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, U.S., Through 2013 (Millions)
Figure U.S. Population, 1998-2013 (Millions)
Table Demographic Trends, U.S., Through 2013 (Millions)
The U.S. Healthcare System
Healthcare Expenditures In The U.S.
Figure U.S. Healthcare Expenditures, 1980-2006 ($ Billions)
Table Healthcare Expenditure, U.S., 2000 And 2006
Table Most Expensive Medical Conditions, U.S., 2004 ($ Billions, %)
Table Prescription Drug Expenditures By Category, 2006 ($ Billions)
Common Health Problems In The U.S.
Table Leading Causes Of Death, U.S. 1997-2005 (%)
Alzheimers Disease (Ad) And Related Dementias
Obesity And Related Conditions
Diabetes
Cardiovascular Disease
Table Cardiovascular Disease, U.S., 2005 (%)
Smoking
Cancer
Table Invasive Cancer, U.S., 2004 (%)
Table Cancer Deaths, U.S., 2004 (%)
Table Cancer Deaths, U.S., 2004 (Ratio Of Deaths: New Cases)
Hiv Infection
Government Regulations
Introduction
Drug Discovery
Preclinical Testing And Submission Of An Ind
Clinical Trials
Timeline And Costs
Submission Of An Nda Or Bla
Post-Fda Approval
New Drug Approvals
Figure Nme Approvals, 1997-2007
Figure Nme Approvals In Two Seven-Year Periods, 1994-2007
Table New Molecular Entities Approved By The Fda, 1980 To March 20, 2007
Do Current Corporate Management Practices Have A Role In R&D Shortfalls?
Blockbuster Drugs
Table Nme Approvals By Disorder, 2004march 20, 2008
Other Successful Therapeutic Agents
Table Botox Sales, 1993-2012 ($ Millions)
Is The Nih Funding Crisis Contributing To Shortfalls In Drug Discovery?
Pharmaceutical Pricing
Factors Affecting Drug Prices
Pharmacy Benefit Managers (Pbms)
Table Market Share: Pharmacy Benefit Managers, 2007 (%)
Pharmacy Benefit Managers (Continued)
Pharmaceutical Flow From Manufacturer To Patient
Pharmaceutical Wholesaling
Table Market Share: U.S. Wholesalers, 2007 (%, $ Billions)
Pharmaceutical Retailing
Table Leading Drug Retailers Rx Volume, U.S., 2002 And 2007 (Rx Millions)
Exportimport Profile
Table Exportimport Profile, U.S., 19952006 ($ Billions)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Table Top Selling U.S. Drugs, 2006 And 2007 ($ Billions)
Generic Drugs
Table Generic Prescription Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Over-The-Counter (Otc) Medications In The U.S.
Table Otc Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Important Organizations In The U.S.
Phrma, The Pharmaceutical Research And Manufacturers Of America
Gpha, Generic Pharmaceutical Association
Chpa (Consumer Healthcare Products Association)
Company Profiles: United States
Abbott Laboratories
Biogen Idec
Amgen
Bristol-Myers Squibb
Forest Laboratories
Genentech51
Genzyme
Johnson & Johnson
Eli Lilly And Company
Merck & Co. Inc.
Pfizer
Wyeth Pharmaceuticals
Teva Pharmaceuticals
Teva North America
Canada
Introduction
Table Overall Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Canada, Through 2013 (Millions)
Figure Canada: Population 1998-2013 (Millions)
Table Demographic Trends, Canada, Through 2013 (Millions)
The Canadian Healthcare System
Healthcare Expenditure In Canada
Table Healthcare Expenditure: Canada, 2000 And 2005
Common Health Problems In Canada
Alzheimers Disease And Related Dementias
Obesity And Related Conditions
Diabetes
Cardiovascular Disease And Cancer
Hiv Infection
Pharmaceutical Pricing
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Over-The-Counter (Otc) Medications In Canada
Table Otc Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Table Top Selling Categories Of Otc Medications In Canada (%)
Important Organizations In Canada
Statistics Canada
Rx&D, Canadas Research-Based Pharmaceutical Companies
Cgpa (Canadian Generic Pharmaceutical Association)
Ndmac (The Nonprescription Drug Manufacturers Association Of Canada)
Company Profiles: Canada
Abbott Laboratories, Limited
Actelion
Astrazeneca Canada Inc.
Bayer, Inc.
Bristol-Myers Squibb Canada
Eli Lilly Canada Inc.
Glaxosmithkline Inc.
Hoffmann-La Roche Limited
Lundbeck Canada Inc.
Merck Frosst Canada Ltd.
Novartis Pharmaceuticals Canada Inc.
Pfizer Canada Inc.
Purdue Pharma (1956)
Sanofi-Aventis Canada
Solvay Pharma Inc
Wyeth Pharmaceuticals
Wyeth Pharmaceuticals (Continued)
Mexico
Introduction
Table Overall Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Mexico, Through 2013 (Millions)
The Mexican Healthcare System
Healthcare Expenditure In Mexico
Table Healthcare Expenditure: Mexico, 2000-2005
Common Health Problems In Mexico
Obesity And Related Conditions
Diabetes: The Leading Cause Of Death
Hiv Infection
Pharmaceutical Regulation And Pricing
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Over-The-Counter (Otc) Medications In Mexico
Table Otc Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Important Organizations In Mexico
Statistics Mexico: Sistemas Nacionales Estadstico Y De Informacin Geogrfica (Sneig)
Afamela (Asociacion De Fabricantes De Medicamentos De Libre Acceso Ac)
Amiif (Asociacin Mexicana De Industriales De Investigacin Farmacutia A.C., Mexican Association Of Pharmaceutical Companies)
Canifarma (Camara Nacional De La Industria Farmaceutica)
Fifarma, The Latin American Federation Of The Pharmaceutical Industry
Ilar (Industrio Latinoaermicana De Automedicacion Responsable)
Brazil
Introduction
Table Overall Pharmaceutical Market, Brazil, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Brazil, Through 2013 (Millions)
Healthcare And Health Problems In Brazil
The Healthcare System (Medicare)
Pharmaceutical Pricing
Health Problems In Brazil
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Brazil, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Brazil, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Brazil, Through 2013 ($ Millions)
Important Organizations In Brazil
Brazilian Institute Of Geography And Statistics
Europe
Healthcare In Europe
Reimbursement Of Pharmaceuticals
Population Demographics In Europe
Population Growth, Median Age, And Life Expectancy
Excess Weight
Life Expectancy In Europe
Pharmaceutical Markets In Europe
Table Top Five Pharmaceutical Markets, Europe, Through 2013 ($ Billions)
Proprietary Prescription Medications (Also Called Branded Medications And Ethical Pharmaceuticals)
Table Branded Prescription Pharmaceuticals Market By Value, Europe, Through 2013 ($ Billions)
Data Exclusivity
Generic Medications
Table Generic Pharmaceuticals Market By Value, Europe, Through 2013 ($ Billions)
Generic Small Molecules
Biosimilars
Over-The-Counter Medications
Table Otc Pharmaceuticals Market By Value, Europe, Through 2013 ($ Billions)
France
Introduction
Table Overall Pharmaceutical Market, France, Through 2013 ($ Billions)
Drivers Of Pharmaceutical Sales Growth
Population And Demographics
Table Population Trends, France, Through 2013 (Millions)
Figure France: Population, 1998-2013 (Millions)
Table Demographic Trends, France, Through 2013 (Millions)
Healthcare Expenditure In France
Table Healthcare Expenditure: France, 2000-2005
Common Health Problems In France
Alzheimers Disease And Related Dementias
Table Dementia In France, 2005-(Millions Of People)
Obesity And Related Conditions
Diabetes
Cardiovascular Disease
Table Percentage Of Spending On Pharmaceuticals By Class, France, 2006 (%)
Pharmaceutical Pricing
Figure Value Breakdown Of Pharmaceuticals, France, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, France, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, France, Through 2013 ($ Billions)
Figure Leading Generic Manufacturers, Market Share, France, 2006 (% Share)
Drivers And Restraints
Over-The-Counter (Otc) Medications In France
Table Otc Pharmaceutical Market, France, Through 2013 ($ Billions)
Table Reasons For Adult Purchases Of Otc Medications In France (%)
Exportimport Profile
Table Pharmaceutical Exports, France, 2000 And 2006 ($ Billions)
Table Pharmaceutical Imports, France, 2005 And 2006 ($ Billions)
Pharmaceutical Distribution
Wholesalers
Figure Leading Wholesalers Market Share, France, 20062007 (% Share)
Frances Pharmaceutical Exports And Imports In Euros
Table Pharmaceutical Exports, France, 2000 And 2006 (Euros, Millions)
Table Pharmaceutical Imports, France, 2005 And 2006 (Euros, Millions)
Important Organizations In France
Insee (National Institute For Statistics And Economic Studies)
Leem, The French Pharmaceutical Companies Association
Csrp (Syndicate Of Pharmaceutical Distributors:
France Alzheimer:
Company Profiles: France
Biogaran
Cerp
Merck Generiques
Sandoz: (See Germany)
Sanofi-Aventis
Sanofi-Aventis (Continued)
Germany
Introduction
Table Overall Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Germany, Through 2013 (Millions)
Table Demographic Trends, Germany, Through 2013 (Millions)
Figure Germany: Population 1998-2013 (Millions)
The German Healthcare System
Healthcare Expenditure In Germany
Table Healthcare Expenditure: Germany, 2000-2005
Common Health Problems In Germany
Alzheimers Disease And Related Dementias
Table Dementia In Germany, 2005-(Millions Of People)
Obesity And Related Conditions
Diabetes
Cardiovascular Disease
Table Expenditures By Therapy Area, Germany (Percentage Of Healthcare Spending, Rounded)
Pricing And Reimbursement Of Pharmaceutical Agents
Figure Value Breakdown Of Pharmaceuticals, Germany, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Drivers And Restraints
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Table Leading Otc Products, Germany, 2006 (%)
Pharmaceutical Distribution
Wholesalers
Figure Leading Wholesalers Market Share, Germany, 20062007 (% Share)
German Pharmaceutical Exports And Imports In Euros
Table Pharmaceutical Exports, Germany, 2005 And 2006 (Euros, Millions)
Table Pharmaceutical Imports, Germany, 2005 And 2006 (Euros, Millions)
Important Organizations In Germany
Destatis (Federal Statistical Office)
German Federal Ministry For Education And Research
Deutsche Diabetes-Union
Pharma Privat
Bah, Bundesverband Der Arzneimittel-Hersteller E..
Vfa, The German Association Of Research-Based Pharmaceutical Companies
Company Profiles: Germany
Celesio Ag
Merck Kgaa
Sandoz
Stada Arzneimittel Ag
United Kingdom (U.K.)
Introduction
Table Overall Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Drivers Of Pharmaceutical Sales Growth
Population And Demographics
Table Population Trends, U.K., Through 2013 (Millions)
Figure U.K. Population, 1998-2013 (Millions)
Table Demographic Trends, U.K., Through 2013 (Millions)
The U.K. Healthcare System
Healthcare Expenditure In The U.K.
Table Healthcare Expenditure: U.K., 2000-2005
Common Health Problems In The U.K.
Alzheimers Disease (Ad) And Related Dementias
Table Prevalence Of Dementia In The U.K. 2005-(Millions Of People)
Obesity And Related Conditions
Diabetes
Cardiovascular Disease (Including Heart Disease And Stroke)
Table Percentage Of Prescription Of Pharmaceuticals By Top Eight Classes, U.K., 2006 (%)
Table Percentage Of Prescription Of Pharmaceuticals, By Class, U.K., 2006 ($ Millions)
Barriers To Pharmaceutical Revenue Growth In The U.K. And Revenue Breakdown
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Table Leading Pharmaceutical Companies, U.K., 2004 (% Of Total Market)
Generic Drugs
Table Generic Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Drivers And Restraints
Over-The-Counter (Otc) Medications In The U.K.
Table Otc Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Table Leading Otc Categories, 2006, U.K. (% Of Total Market)
Exportimport Profile
Table Pharmaceutical Exportsimports, U.K., 19972006 ($ Billions)
Pharmaceutical Distribution
Wholesalers
Table Leading Pharmaceutical Distributors, U.K. (% Of Total Market)
U.K.s Pharmaceutical Exports And Imports In Pounds Sterling
Table Pharmaceutical Exports, U.K., 1997-2006 ( Billions)
Important Organizations In The U.K.
National Statistics U.K.
Abpi, The Association Of The British Pharmaceutical Industry
The British Association Of Pharmaceutical Wholesalers (Bapw)
Company Profiles: U.K.
Aah Pharmaceuticals
Glaxosmithkline (Gsk)
Mawdsley-Brooks & Co. Ltd.
Phoenix Healthcare Distribution, Ltd.
Unichem
Unichem (Continued)
Italy
Introduction
Table Overall Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Drivers Of Pharmaceutical Sales Growth
Population And Demographics
Table Population Trends, Italy, Through 2013 (Millions)
Figure Italy: Population, 1998-2013 (Millions)
Table Demographic Trends, Italy, Through 2013 (Millions)
The Italian Healthcare System And Growth Drivers
Table Healthcare Expenditure: Italy, 2000-2005
Common Health Problems In Italy
Alzheimers Disease (Ad) And Related Dementias
Obesity And Related Conditions
Diabetes
Cardiovascular Disease (Including Heart Disease And Stroke)
Table Percentage Of Class C Prescription Pharmaceuticals By Class, Italy, 2006 (%)
Barriers To Pharmaceutical Revenue Growth In Italy
Revenue Breakdown Of Pharmaceutical Products In Italy
Figure Value Breakdown Of Pharmaceuticals, Italy, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Drivers And Restraints
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Table Leading Otc Categories, Italy, 2006 (% Of Total Market)
Exportimport Profile
Table Pharmaceutical Exports, Italy, 2005 And 2006 ($ Billions, Rounded)
Table Leading Destinations Of Italian Pharmaceutical Exports, 2006 (% Of Total Market)
Table Pharmaceutical Imports, Italy, 2005 And 2006 ($ Billions)
Table Leading Destinations Of Italian Pharmaceutical Imports, 2006 (% Of Total Market)
Italys Pharmaceutical Exports And Imports In Euros
Table Pharmaceutical Exports, Italy, 2005 And 2006 ( Billions)
Table Pharmaceutical Imports, Italy, 2005 And 2006 ( Billions)
Important Organizations In Italy
National Institute For Statistics (Istituto Nazionale Di Statistica)
Farmindustria, The Pharmaceutical Manufacturers Association Of Italy
Assogenerici, The Italian National Association Of Generic Pharmaceuticals
Spain
Introduction
Table Overall Pharmaceutical Market, Spain, Through 2013 ($ Billions)
Drivers Of Pharmaceutical Sales Growth
Population And Demographics
Table Population Trends, Spain, Through 2013 (Millions)
Figure Spain: Population, 1998-2013 (Millions)
Table Demographic Trends, Spain, Through 2013 (Millions)
The Spanish Healthcare System, Pricing, And Pharmaceutical Growth Drivers
The Healthcare System
Table Healthcare Expenditure: Spain, 2000-2005
Drug Pricing Policies
Common Health Problems In Spain
Alzheimers Disease (Ad) And Related Dementias
Obesity And Related Conditions
Diabetes
Cardiovascular Disease (Including Heart Disease And Stroke)
Table Percentage Of Prescription Of Pharmaceuticals, By Class, Spain, 2006
Growth Drivers
Barriers To Pharmaceutical Revenue Growth In Spain
Revenue Breakdown Of Pharmaceutical Products In Spain
Figure Value Breakdown Of Pharmaceuticals, Spain, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Spain, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Spain, Through 2013 ($ Billions)
Drivers And Restraints
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Spain, Through 2013 ($ Millions)
Exportimport Profile
Table Pharmaceutical Exports, Spain, 2005 And 2006 (%)
Table Pharmaceutical Imports, Spain, 2005 And 2006 (%)
Important Organizations In Spain
National Statistics Institute (Instituto Nacional De Estadistica)
Farmaindustria, The National Association Of The Pharmaceutical Industry In Spain
Aeseg, The Spanish Association Of Generic Pharmaceuticals Manufacturers
Anefp, The Nationals Association Of Over-The-Counter Medications
Ceafa, Confederaction Espanola De Familiares Enfermos De Alzheimers Y Otras Demencias
Smaller Pharmaceutical Markets In Europe
Greece
Introduction
Table Overall Pharmaceutical Market, Greece, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Greece, Through 2013 (Millions)
Figure Greece: Population, 1998-2013
(Millions)
Table Demographic Trends, Greece, Through 2013 (Millions)
The Greek Healthcare System
Structure Of The Healthcare System
Healthcare Expenditures
Table Healthcare Expenditure: Greece, 2000-2005
Common Health Problems In Greece
Pharmaceutical Pricing
Table Percentage Of Prescription Pharmaceuticals, By Class, Greece, 2004
Revenue Breakdown Of Pharmaceutical Products In Greece
Figure Value Breakdown Of Pharmaceuticals, Greece, 2005 (%)
Growth Drivers
Barriers To Pharmaceutical Revenue Growth In Greece
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Greece, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Greece, Through 2013 ($ Billions)
Drivers And Restraints
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Greece, Through 2013 ($ Millions)
Table Leading Otc Categories, Greece, 2006 (% Of Total Market)
Important Organizations In Greece
Statistics Greece
The Hellenic Association Of Pharmaceutical Companies (Sfee)
Efex, The Greek Proprietary Association
The Netherlands
Introduction
Table Overall Pharmaceutical Market, Netherlands, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Netherlands, Through 2013 (Millions)
Figure Netherlands: Population, 1998-2013 (Millions)
Table Demographic Trends, Netherlands, Through 2013 (Millions)
The Dutch Healthcare System
Structure Of The Healthcare System
Healthcare Expenditures
Table Healthcare Expenditure: The Netherlands, 2000-2005
Common Health Problems In The Netherlands
Drug Pricing
Revenue Breakdown Of Pharmaceutical Products In The Netherlands
Figure Value Breakdown Of Pharmaceuticals, Netherlands, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Netherlands, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Netherlands, Through 2013 ($ Billions)
Drivers And Restraints
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Netherlands, Through 2013 ($ Millions)
Table Leading Otc Categories, Netherlands, 2006 (% Of Total Market)
Important Organizations In The Netherlands
Statistics Netherlands
Nefarma, The Association Of Innovate Pharmaceuticals In The Netherlands
Bogin, The Association Of Dutch Generic Medications Industry
Nepropharm, The Netherlands Association Of Over-The-Counter Products
Belgium
Introduction
Table Overall Pharmaceutical Market, Belgium, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Belgium, Through 2013 (Millions)
Figure Belgium: Population, 1998-2013 (Millions)
Table Demographic Trends, Belgium, Through 2013 (Millions)
The Belgian Healthcare System
Structure Of The Healthcare System
Table Healthcare Expenditure: Belgium, 2000-2005
Common Health Problems In Belgium
Drug Pricing
Revenue Breakdown Of Pharmaceutical Products In Belgium
Figure Value Breakdown Of Pharmaceuticals, Belgium, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Belgium, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Belgium, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Belgium, Through 2013 ($ Millions)
Table Leading Otc Categories, Belgium, 2006 (% Of Total Market)
Important Organizations In Belgium
Statistics Belgium
Pharma.Be, The General Association Of The Medicines Industry
Eurogenerics
Poland
Introduction
Table Overall Pharmaceutical Market, Poland, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Poland, Through 2013 (Millions)
Figure Poland: Population, 1998-2013 (Millions)
Table Demographic Trends, Poland, Through 2013 (Millions)
Common Health Problems In Poland
The Polish Healthcare System
Structure Of The Healthcare System
Table Healthcare Expenditure: Poland, 2000-2005
Drug Pricing
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Poland, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Poland, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Poland, Through 2013 ($ Millions)
Table Leading Otc Categories, Poland, 2006 (% Of Total Market)
Important Organizations In Poland
Polish Central Statistics Office
Polfarmed, Polish Chamber Of Pharmaceuticals Industry And Medical Devices
Pasmi, The Polish Association Of The Self-Medication Industry
Portugal
Introduction
Table Overall Pharmaceutical Market, Portugal, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Portugal, Through 2013 (Millions)
Figure Portugal: Population, 1998-2013 (Millions)
Table Demographic Trends, Portugal, Through 2013 (Millions)
The Portuguese Healthcare System
Structure Of The Healthcare System
Table Healthcare Expenditure: Portugal, 2000-2005
Pharmaceutical Pricing
Figure Value Breakdown Of Pharmaceuticals, Portugal, 2005 (%)
Common Health Problems In Portugal
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Portugal, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Portugal, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Portugal, Through 2013 ($ Millions) 234
Table Leading Otc Categories, Portugal, 2006 (% Of Total Market) 234
Important Organizations In Portugal 234
Statistics Portugal 234
Apogen, Portuguese Association Of Generic Medications
Apifarma, The Association Of The Portuguese Pharmaceutical Industry
Switzerland
Introduction
Table Overall Pharmaceutical Market, Switzerland, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Switzerland, Through 2013 (Millions)
Figure Switzerland: Population, 1998-2013 (Millions)
Table Demographic Trends, Switzerland, Through 2013 (Millions)
Common Health Problems In Switzerland
The Swiss Healthcare System
Structure Of The Healthcare System
Table Healthcare Expenditure: Switzerland, 2000-2005
Pharmaceutical Environment And Pricing
Pharmaceutical Environment (Continued)
Figure Value Breakdown Of Pharmaceuticals, Switzerland, 2005 (%)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Switzerland, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Switzerland, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Switzerland, Through 2013 ($ Millions)
Table Leading Otc Categories, Switzerland, 2006 (% Of Total Market)
Important Organizations In Switzerland
Swiss Federal Statistics Office
Company Profiles
Novartis International Ag
Sweden
Introduction
Table Overall Pharmaceutical Market, Sweden, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Sweden, Through 2013 (Millions)
Figure Sweden: Population, 1998-2013 (Millions)
Table Demographic Trends, Sweden, Through 2013 (Millions)
Health Problems And Healthcare In Sweden
The Healthcare System
Table Healthcare Expenditure: Sweden, 2000-2005
Pharmaceutical Pricing
Figure Value Breakdown Of Pharmaceuticals, Sweden, 2005 (%)
Health Problems In Sweden
Table Leading Therapeutic Categories, Sweden, 2006 (% Of Total Market, By Value)
Market Sectors
Branded Pharmaceuticals
Table Branded Pharmaceutical Market, Sweden, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Sweden, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Sweden, Through 2013 ($ Millions)
Important Organizations In Sweden
Statistics Sweden
Fgl, The Swedish Association For Generic Pharmaceuticals
Austria
Introduction
Table Overall Pharmaceutical Market, Austria, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Austria, Through 2013 (Millions)
Figure Austria: Population, 1998-2013 (Millions)
Table Demographic Trends, Austria, Through 2013 (Millions)
Healthcare And Health Problems In Austria
The Healthcare System
Pharmaceutical Pricing
Table Healthcare Expenditure: Austria, 2000-2005
Health Problems In Austria
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Austria, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Austria, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Austria, Through 2013 ($ Millions)
Important Organizations In Austria
Statistics Austria
Pharmig, The
Igepha, The Austrian Self-Medication Industry
Hungary
Introduction
Table Overall Pharmaceutical Market, Hungary, Through 2013 ($ Billions)
Population And Demographics
Health Problems And Healthcare In Hungary
The Healthcare System
Pharmaceutical Pricing
Health Problems In Hungary
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Hungary, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Hungary, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Hungary, Through 2013 ($ Millions)
Important Organizations In Hungary
Hungarian Central Statistics Office
Magyosz, The Hungarian Pharmaceutical Manufacturers Association
Finland
Introduction
Table Overall Pharmaceutical Market, Finland, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Finland, Through 2013 (Millions)
Table Demographic Trends, Finland, Through 2013 (Millions)
Health Problems And Healthcare In Finland
The Healthcare System
Pharmaceutical Pricing
Health Problems In Finland
Market Sectors
Table Leading Therapeutic Categories, Finland, 2006 (% Of Total Market, By Value)
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Finland, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Finland, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Finland, Through 2013 ($ Millions)
Important Organizations In Finland
Statistics Finland
Important Organizations In Europe
The European Federation Of Pharmaceutical Industries And Associations (Efpia)
The European Generics Association (Ega)
The Association Of The European Self-Medication Industry (Aesgp)
Asia
Japan
Introduction
Table Overall Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Japan, Through 2013 (Millions)
Table Demographic Trends, Japan, Through 2013 (Millions)
Figure Japan: Population, 1998-2013 (Millions)
The Japanese Healthcare System
Healthcare Expenditures In Japan
Table Healthcare Expenditure: Japan, 2000-2005
Common Health Problems In Japan
Table Leading Causes Of Death, Japan, 2005
Cancer
Table Leading Forms Of Cancer, Japan, 2005
Alzheimers Disease And Related Dementias
Obesity And Diabetes
Cardiovascular Disease
Smoking
Pharmaceutical Pricing
Pharmaceutical Pricing (Continued)
Pricing Of Generic Drugs
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Over-The-Counter Medications In Japan
Table Otc Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Table Leading Otc Categories, Japan
Important Organizations In Japan
Statistics Bureau
Ministry Of Health, Labour, & Welfare
Jpma, Japan Pharmaceutical Manufacturers Association
Jsmi, Japanese Self-Medication Industry
Company Profiles
Astellas Pharma
Sawai Pharmaceutical Company Ltd.
Takeda Pharmaceutical Company Ltd.
China
Introduction
Table Overall Pharmaceutical Market, China, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, China, Through 2013 (Millions)
Table Demographic Trends, China, Through 2013 (Millions)
Healthcare And Health Problems In China
The Healthcare System
Pharmaceutical Pricing
Health Problems In China
Market Sectors
Branded Prescription Pharmaceuticals
Table Prescription Pharmaceutical Market, China, Through 2013 ($ Billions)
Generic Drugs
Over-The-Counter Medications
Table Otc Pharmaceutical Market, China, Through 2013 ($ Millions)
Important Organizations In China
National Bureau Of Statistics Of China
South Korea
Introduction
Table Overall Pharmaceutical Market, South Korea, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, South Korea, Through 2013 (Millions)
Table Demographic Trends, South Korea, Through 2013 (Millions)
Healthcare And Health Problems In South Korea
The Healthcare System
Pharmaceutical Pricing
Health Problems In South Korea
Table Leading Causes Of Death, South Korea, 2003
Market Sectors
Branded And Generic Prescription Pharmaceuticals
Table Prescription Pharmaceutical Market, South Korea, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, South Korea, Through 2013 ($ Millions)
Important Organizations In South Korea
Korean National Statistical Office
Australia
Introduction
Table 2overall Pharmaceutical Market, Australia, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, Australia, Through 2013 (Millions)
Healthcare And Health Problems In Australia
The Healthcare System (Medicare)
Pharmaceutical Pricing
Health Problems In Australia
Table Leading Causes Of Death, Men, Australia, 2005 (% Of All Deaths)
Table 2leading Causes Of Death, Women, Australia, 2004 (% Of All Deaths)
Table Common Chronic Conditions, Australia, 2005 (% Of Population)
Market Sectors
Branded Prescription Pharmaceuticals
Table Branded Pharmaceutical Market, Australia, Through 2013 ($ Billions)
Generic Drugs
Table Generic Pharmaceutical Market, Australia, Through 2013 ($ Billions)
Over-The-Counter Medications
Table Otc Pharmaceutical Market, Australia, Through 2013 ($ Millions)
Table Top Otc Purchases, Australia (% Of The Population)
Important Organizations In Australia
Australian Bureau Of Statistics
Department Of Innovation, Industry, Science, And Research
Medicines Australia
India
Introduction
Table Overall Pharmaceutical Market, India, Through 2013 ($ Billions)
Population And Demographics
Table Population Trends, India, Through 2013 (Millions)
Healthcare And Health Problems In India
Pharmaceutical Pricing
Health Problems In India
Market Sectors
Overview
Table Top Indian Pharmaceutical Companies By Revenues, 2006 ($ Millions)
Barriers To Growth In India
Branded Prescription Pharmaceuticals
Table Prescription Pharmaceutical Market, India, Through 2013 ($ Billions)
Generics
Over-The-Counter Medications
Tableotc Pharmaceutical Market, India, Through 2013 ($ Billions)
Important Organizations In India
Ministry Of Statistics And Programme Implementation
Ministry Of Health
Idma, The Indian Drug Manufacturers Association
Oppi, The Organisation Of Pharmaceutical Producers Of India
Company Profiles
Ranbaxy Laboratories, Ltd
Cipla Ltd.
Dr. Reddys Laboratories Ltd.
Some Interesting Links Related To Health, Pharmaceuticals, And Disease
Pharmaceutical Markets In Selected Countries Not Covered In Detail In This Report
Pharmaceutical Markets In Selected Countries
Pharmaceutical Markets
Some Interesting Links Related To Health, Pharmaceuticals, And Disease
Table Healthcare Expenditures, Countries In This Report, 2000 And 2005 (% Of Gdp)
Table Worldwide Leading Ethical Pharmaceutical Companies: Sales And Market Share, 2006 And 2007 ($ Billions)
Table Worldwide Leading Pharmaceutical Companies By R&D Spending, 2006 And 2007 ($ Billions)
Table Largest Pharmaceutical Markets (Overall), 2006 And 2007 ($ Billions, % Of Total)
Table Largest Pharmaceutical Markets (Branded), 2006 And 2007 ($ Billions, % Of Total)
Table Worldwide Leading Pharmaceutical Largest Pharmaceutical Markets (Generic), 2006 And 2007 ($ Billions, % Of Total)
Table Largest Pharmaceutical Markets (Otc), 2006 And 2007 ($ Billions, % Of Total)
Table Overall Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Table Population Trends, U.S., Through 2013 (Millions)
Table Demographic Trends, U.S., Through 2013 (Millions)
Table Healthcare Expenditure, U.S., 2000 And 2006
Table Most Expensive Medical Conditions, U.S., 2004 ($ Billions, %)
Table Prescription Drug Expenditures By Category, 2006 ($ Billions)
Table Leading Causes Of Death, U.S. 1997-2005 (%)
Table Cardiovascular Disease, U.S., 2005 (%)
Table Invasive Cancer, U.S., 2004 (%)
Table Cancer Deaths, U.S., 2004 (%)
Table Cancer Deaths, U.S., 2004 (Ratio Of Deaths: New Cases)
Table New Molecular Entities Approved By The Fda, 1980 To March 20, 2007
Table Nme Approvals By Disorder, 2004march 20, 2008
Table Botox Sales, 1993-2012 ($ Millions)
Table Market Share: Pharmacy Benefit Managers, 2007 (%)
Table Market Share: U.S. Wholesalers, 2007 (%, $ Billions)
Table Leading Drug Retailers Rx Volume, U.S., 2002 And 2007 (Rx Millions)
Table Exportimport Profile, U.S., 19952006 ($ Billions)
Table Branded Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Table Top Selling U.S. Drugs, 2006 And 2007 ($ Billions)
Table Generic Prescription Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, U.S., Through 2013 ($ Billions)
Table Overall Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Table Population Trends, Canada, Through 2013 (Millions)
Table Demographic Trends, Canada, Through 2013 (Millions)
Table Healthcare Expenditure: Canada, 2000 And 2005
Table Branded Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Canada, Through 2013 ($ Billions)
Table Top Selling Categories Of Otc Medications In Canada (%)
Table Overall Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Table Population Trends, Mexico, Through 2013 (Millions)
Table Healthcare Expenditure: Mexico, 2000-2005
Table Branded Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Mexico, Through 2013 ($ Billions)
Table Overall Pharmaceutical Market, Brazil, Through 2013 ($ Billions)
Table Population Trends, Brazil, Through 2013 (Millions)
Table Branded Pharmaceutical Market, Brazil, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Brazil, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Brazil, Through 2013 ($ Millions)
Table Top Five Pharmaceutical Markets, Europe, Through 2013 ($ Billions)
Table Branded Prescription Pharmaceuticals Market By Value, Europe, Through 2013 ($ Billions)
Table Generic Pharmaceuticals Market By Value, Europe, Through 2013 ($ Billions)
Table Otc Pharmaceuticals Market By Value, Europe, Through 2013 ($ Billions)
Table Overall Pharmaceutical Market, France, Through 2013 ($ Billions)
Table Population Trends, France, Through 2013 (Millions)
Table Demographic Trends, France, Through 2013 (Millions)
Table Healthcare Expenditure: France, 2000-2005
Table Dementia In France, 2005-(Millions Of People)
Table Percentage Of Spending On Pharmaceuticals By Class, France, 2006 (%)
Table Branded Pharmaceutical Market, France, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, France, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, France, Through 2013 ($ Billions)
Table Reasons For Adult Purchases Of Otc Medications In France (%)
Table Pharmaceutical Exports, France, 2000 And 2006 ($ Billions)
Table Pharmaceutical Imports, France, 2005 And 2006 ($ Billions)
Table Pharmaceutical Exports, France, 2000 And 2006 (Euros, Millions)
Table Pharmaceutical Imports, France, 2005 And 2006 (Euros, Millions)
Table Overall Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Table Population Trends, Germany, Through 2013 (Millions)
Table Demographic Trends, Germany, Through 2013 (Millions)
Table Healthcare Expenditure: Germany, 2000-2005
Table Dementia In Germany, 2005-(Millions Of People)
Table Expenditures By Therapy Area, Germany (Percentage Of Healthcare Spending, Rounded)
Table Branded Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Germany, Through 2013 ($ Billions)
Table Leading Otc Products, Germany, 2006 (%)
Table Pharmaceutical Exports, Germany, 2005 And 2006 (Euros, Millions)
Table Pharmaceutical Imports, Germany, 2005 And 2006 (Euros, Millions)
Table Overall Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Table Population Trends, U.K., Through 2013 (Millions)
Table Demographic Trends, U.K., Through 2013 (Millions)
Table Healthcare Expenditure: U.K., 2000-2005
Table Prevalence Of Dementia In The U.K. 2005-(Millions Of People)
Table Percentage Of Prescription Of Pharmaceuticals By Top Eight Classes, U.K., 2006 (%)
Table Percentage Of Prescription Of Pharmaceuticals, By Class, U.K., 2006 ($ Millions)
Table Branded Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Table Leading Pharmaceutical Companies, U.K., 2004 (% Of Total Market)
Table Generic Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, U.K., Through 2013 ($ Billions)
Table Leading Otc Categories, 2006, U.K. (% Of Total Market)
Table Pharmaceutical Exportsimports, U.K., 19972006 ($ Billions)
Table Leading Pharmaceutical Distributors, U.K. (% Of Total Market)
Table Pharmaceutical Exports, U.K., 1997-2006 ( Billions)
Table Overall Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Table Population Trends, Italy, Through 2013 (Millions)
Table Demographic Trends, Italy, Through 2013 (Millions)
Table Healthcare Expenditure: Italy, 2000-2005
Table Percentage Of Class C Prescription Pharmaceuticals By Class, Italy, 2006 (%)
Table Branded Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Italy, Through 2013 ($ Billions)
Table Leading Otc Categories, Italy, 2006 (% Of Total Market)
Table Pharmaceutical Exports, Italy, 2005 And 2006 ($ Billions, Rounded)
Table Leading Destinations Of Italian Pharmaceutical Exports, 2006 (% Of Total Market)
Table Pharmaceutical Imports, Italy, 2005 And 2006 ($ Billions)
Table Leading Destinations Of Italian Pharmaceutical Imports, 2006 (% Of Total Market)
Table Pharmaceutical Exports, Italy, 2005 And 2006 ( Billions)
Table Pharmaceutical Imports, Italy, 2005 And 2006 ( Billions)
Table Overall Pharmaceutical Market, Spain, Through 2013 ($ Billions)
Table Population Trends, Spain, Through 2013 (Millions)
Table Demographic Trends, Spain, Through 2013 (Millions)
Table Healthcare Expenditure: Spain, 2000-2005
Table Percentage Of Prescription Of Pharmaceuticals, By Class, Spain, 2006
Table Branded Pharmaceutical Market, Spain, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Spain, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Spain, Through 2013 ($ Millions)
Table Pharmaceutical Exports, Spain, 2005 And 2006 (%)
Table Pharmaceutical Imports, Spain, 2005 And 2006 (%)
Table Overall Pharmaceutical Market, Greece, Through 2013 ($ Billions)
Table Population Trends, Greece, Through 2013 (Millions)
Table Demographic Trends, Greece, Through 2013 (Millions)
Table Healthcare Expenditure: Greece, 2000-2005
Table Percentage Of Prescription Pharmaceuticals, By Class, Greece, 2004
Table Branded Pharmaceutical Market, Greece, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Greece, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Greece, Through 2013 ($ Millions)
Table Leading Otc Categories, Greece, 2006 (% Of Total Market)
Table Overall Pharmaceutical Market, Netherlands, Through 2013 ($ Billions)
Table Population Trends, Netherlands, Through 2013 (Millions)
Table Demographic Trends, Netherlands, Through 2013 (Millions)
Table Healthcare Expenditure: The Netherlands, 2000-2005
Table Branded Pharmaceutical Market, Netherlands, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Netherlands, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Netherlands, Through 2013 ($ Millions)
Table Leading Otc Categories, Netherlands, 2006 (% Of Total Market)
Table Overall Pharmaceutical Market, Belgium, Through 2013 ($ Billions)
Table Population Trends, Belgium, Through 2013 (Millions)
Table Demographic Trends, Belgium, Through 2013 (Millions)
Table Healthcare Expenditure: Belgium, 2000-2005
Table Branded Pharmaceutical Market, Belgium, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Belgium, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Belgium, Through 2013 ($ Millions)
Table Leading Otc Categories, Belgium, 2006 (% Of Total Market)
Table Overall Pharmaceutical Market, Poland, Through 2013 ($ Billions)
Table Population Trends, Poland, Through 2013 (Millions)
Table Demographic Trends, Poland, Through 2013 (Millions)
Table Healthcare Expenditure: Poland, 2000-2005
Table Branded Pharmaceutical Market, Poland, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Poland, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Poland, Through 2013 ($ Millions)
Table Leading Otc Categories, Poland, 2006 (% Of Total Market)
Table Overall Pharmaceutical Market, Portugal, Through 2013 ($ Billions)
Table Population Trends, Portugal, Through 2013 (Millions)
Table Demographic Trends, Portugal, Through 2013 (Millions)
Table Healthcare Expenditure: Portugal, 2000-2005
Table Branded Pharmaceutical Market, Portugal, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Portugal, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Portugal, Through 2013 ($ Millions) 234
Table Leading Otc Categories, Portugal, 2006 (% Of Total Market) 234
Table Overall Pharmaceutical Market, Switzerland, Through 2013 ($ Billions)
Table Population Trends, Switzerland, Through 2013 (Millions)
Table Demographic Trends, Switzerland, Through 2013 (Millions)
Table Healthcare Expenditure: Switzerland, 2000-2005
Table Branded Pharmaceutical Market, Switzerland, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Switzerland, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Switzerland, Through 2013 ($ Millions)
Table Leading Otc Categories, Switzerland, 2006 (% Of Total Market)
Table Overall Pharmaceutical Market, Sweden, Through 2013 ($ Billions)
Table Population Trends, Sweden, Through 2013 (Millions)
Table Demographic Trends, Sweden, Through 2013 (Millions)
Table Healthcare Expenditure: Sweden, 2000-2005
Table Leading Therapeutic Categories, Sweden, 2006 (% Of Total Market, By Value)
Table Branded Pharmaceutical Market, Sweden, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Sweden, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Sweden, Through 2013 ($ Millions)
Table Overall Pharmaceutical Market, Austria, Through 2013 ($ Billions)
Table Population Trends, Austria, Through 2013 (Millions)
Table Demographic Trends, Austria, Through 2013 (Millions)
Table Healthcare Expenditure: Austria, 2000-2005
Table Branded Pharmaceutical Market, Austria, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Austria, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Austria, Through 2013 ($ Millions)
Table Overall Pharmaceutical Market, Hungary, Through 2013 ($ Billions)
Table Branded Pharmaceutical Market, Hungary, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Hungary, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Hungary, Through 2013 ($ Millions)
Table Overall Pharmaceutical Market, Finland, Through 2013 ($ Billions)
Table Population Trends, Finland, Through 2013 (Millions)
Table Demographic Trends, Finland, Through 2013 (Millions)
Table Leading Therapeutic Categories, Finland, 2006 (% Of Total Market, By Value)
Table Branded Pharmaceutical Market, Finland, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Finland, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Finland, Through 2013 ($ Millions)
Table Overall Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Table Population Trends, Japan, Through 2013 (Millions)
Table Demographic Trends, Japan, Through 2013 (Millions)
Table Healthcare Expenditure: Japan, 2000-2005
Table Leading Causes Of Death, Japan, 2005
Table Leading Forms Of Cancer, Japan, 2005
Table Branded Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Japan, Through 2013 ($ Billions)
Table Leading Otc Categories, Japan
Table Overall Pharmaceutical Market, China, Through 2013 ($ Billions)
Table Population Trends, China, Through 2013 (Millions)
Table Demographic Trends, China, Through 2013 (Millions)
Table Prescription Pharmaceutical Market, China, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, China, Through 2013 ($ Millions)
Table Overall Pharmaceutical Market, South Korea, Through 2013 ($ Billions)
Table Population Trends, South Korea, Through 2013 (Millions)
Table Demographic Trends, South Korea, Through 2013 (Millions)
Table Leading Causes Of Death, South Korea, 2003
Table Prescription Pharmaceutical Market, South Korea, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, South Korea, Through 2013 ($ Millions)
Table 2overall Pharmaceutical Market, Australia, Through 2013 ($ Billions)
Table Population Trends, Australia, Through 2013 (Millions)
Table Leading Causes Of Death, Men, Australia, 2005 (% Of All Deaths)
Table 2leading Causes Of Death, Women, Australia, 2004 (% Of All Deaths)
Table Common Chronic Conditions, Australia, 2005 (% Of Population)
Table Branded Pharmaceutical Market, Australia, Through 2013 ($ Billions)
Table Generic Pharmaceutical Market, Australia, Through 2013 ($ Billions)
Table Otc Pharmaceutical Market, Australia, Through 2013 ($ Millions)
Table Top Otc Purchases, Australia (% Of The Population)
Table Overall Pharmaceutical Market, India, Through 2013 ($ Billions)
Table Population Trends, India, Through 2013 (Millions)
Table Top Indian Pharmaceutical Companies By Revenues, 2006 ($ Millions)
Table Prescription Pharmaceutical Market, India, Through 2013 ($ Billions)
Tableotc Pharmaceutical Market, India, Through 2013 ($ Billions)
Figure U.S. Population, 1998-2013 (Millions)
Figure U.S. Healthcare Expenditures, 1980-2006 ($ Billions)
Figure Nme Approvals, 1997-2007
Figure Nme Approvals In Two Seven-Year Periods, 1994-2007
Figure Canada: Population 1998-2013 (Millions)
Figure France: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, France, 2005 (%)
Figure Leading Generic Manufacturers, Market Share, France, 2006 (% Share)
Figure Leading Wholesalers Market Share, France, 20062007 (% Share)
Figure Germany: Population 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Germany, 2005 (%)
Figure Leading Wholesalers Market Share, Germany, 20062007 (% Share)
Figure U.K. Population, 1998-2013 (Millions)
Figure Italy: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Italy, 2005 (%)
Figure Spain: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Spain, 2005 (%)
Figure Greece: Population, 1998-2013
(Millions)
Figure Value Breakdown Of Pharmaceuticals, Greece, 2005 (%)
Figure Netherlands: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Netherlands, 2005 (%)
Figure Belgium: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Belgium, 2005 (%)
Figure Poland: Population, 1998-2013 (Millions)
Figure Portugal: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Portugal, 2005 (%)
Figure Switzerland: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Switzerland, 2005 (%)
Figure Sweden: Population, 1998-2013 (Millions)
Figure Value Breakdown Of Pharmaceuticals, Sweden, 2005 (%)
Figure Austria: Population, 1998-2013 (Millions)
Figure Japan: Population, 1998-2013 (Millions)